SlideShare a Scribd company logo
Adult-Onset Still’s Disease
Dr. Bella Mehta
Hospital for Special Surgery
Weill Cornell Medical College
@bella_mehta
Overview
• Adult Onset Still’s Disease (AOSD) is a rare autoinflammatory
syndrome
• ~1.6 cases per 1,000,000 individuals, affecting men and women equally
• Most commonly affects patients between 15-25 and 36-46 years old
• Many patients live full, normal lives with proper treatment
Mandl L, et al. Treatment of adult-onset Still's disease. Up to Date. 2021
Why does AOSD occur?
Genetic factors Viral infection Immune dysregulation
Epstein-Barr
Rubella
IL-1 IL-6
IL-17 IL-18
TNF - alpha
Several factors associated with AOSD
AOSD Disease Patterns
Monocyclic/Self-Limited
One flare/active phase
Lasts weeks to months
Usually resolves in <1 year
Systemic features (fever, rash,
serositis)
Intermittent Pattern
≥1 disease flare
Complete remission between
episodes
Articular symptoms
Chronic Pattern
Constant active disease
No remission
Articular symptoms
Destructive arthritis
Still’s Disease Triad
AOSD
Daily fevers
Early afternoon/evening
Evanescent rash
Salmon-pink, on trunk or
extremities, occurs with fever
Arthritis
Small joints more often than
large joints
AOSD Rash
Evanescent (tends to disappear quickly) rash that is most common
during a fever episode
Left image: Courant V, et al. Rare presentation of adult Still's disease in an African American male. Journal of Hospital Medicine, 2022
Center image: Gopalarathinim R, et al. Adult Onset Still's Disease: A Review on Diagnostic Workup and Treatment Options. Case Reports in Rheum, 2016;6:1-6.
Right image: Patra S, et al. Adult-onset Still's disease presenting as blotchy and flagellate pigmentation. Indian J Dermatol Venereol Leprol, 2019;85:626-628.
Clinical Features
Common Symptoms Uncommon Symptoms
Fever Hepatomegaly
(enlarged liver)
Rash Pleurisy
(inflammation of lung lining)
Arthritis Pericarditis
(inflammation of the heart lining)
Arthralgia
(body aches)
Abdominal pain
Myalgias
(muscle pain)
Macrophage activation syndrome (MAS)
Sore Throat
Lymphadenopathy
(swelling of lymph nodes)
Splenomegaly
(enlarged spleen)
Comorbidities
• Our Nationwide study examined variations
in morbidity and mortality 5 year data
• 65.6% of patients were female
• Mean age of pts who died in hospital 62.4
• Higher odds of in-hospital death in Asian
patients
• Other possible complications that may occur in
AOSD include:
• Overwhelming infection
• Liver failure
• Amyloidosis (protein buildup)
5,820 Hospitalized
AOSD Patients
• Heart failure
*Racial/Ethnic variations in morbidity and mortality in Adult Onset Still’s Disease: An analysis of national dataset, Seminars in arthritis and Rheumatism 2019
Goals of Therapy
Vary with severity of disease
1. Control inflammation
2. Prevent joint damage
3. Minimize risk of adverse events
4. Lessen burden of disease
NSAIDS
Corticosteroids
DMARDs
Diagnosis and Next Steps
Confirmation of diagnosis is critical
• Several other systemic conditions have similar symptoms to AOSD
Screen for underlying conditions and immunize if necessary
• Ex. hepatitus virus screening, testing for latent tuberculosis
Determine whether macrophage activation syndrome (MAS) is present
• Also known as a cytokine storm
Assess disease activity and severity
• Informs treatment (ex. medications)
Mandl L, et al. Treatment of adult-onset Still's disease. Up to Date. 2021
Dr. Bella Mehta
Hospital for Special Surgery
Weill Cornell Medical College
Thank You!
Questions?
@bella_mehta
Diagnosis
Efthimiou, P. New York Rheumatology Care, New York, NY. Ross University School of Medicine
1. Yamaguchi M, et al. J Rheumatol. 1992,19:424-430.
2. Fautrel B, et al. Medicine (Baltimore). 2002;81:194-200.
Medications
• Traditional medications
• Nonsteroidal anti-inflammatory drugs (NSAIDs)
• Glucocorticoids
• Biologics
• Canakinumab
• Anakinra
• Infliximab
• Rilonacept
• Etanercept
• Adalimumab
• Tocilizumab
• Rituximab
• Disease-modifying antirheumatic drugs (DMARDs)
• Hydroxychloroquine
• Methotrexate
• Leflunomide
• Cyclosporine
• Azathioprine
• Tacrolimus
Comorbidities
• AOSD is infrequently associated with morbidity and life-threatening
comorbidities
• Complications include:
• Overwhelming infection
• Liver failure
• Amyloidosis (protein buildup in organs)
• Adult respiratory distress syndrome
• Heart failure
• Macrophage activation syndrome (MAS)
• Pulmonary hypertension
Early recognition and
treatment can
significantly
decrease the risk of
complications
Efthimiou P, Mehta B. Life-threatening complications of adult-onset Still’s disease. Clin Rheumatol. 2014;33:305-314.

More Related Content

What's hot

Vasculitis
VasculitisVasculitis
Vasculitis
drangelosmith
 
Hereditary spastic paraplegia
Hereditary spastic paraplegiaHereditary spastic paraplegia
Hereditary spastic paraplegia
Yogasundaram Sasikumar
 
Still's disease
Still's diseaseStill's disease
Still's disease
Wayne Adighibenma
 
Chronic fatigue syndrome
Chronic  fatigue syndromeChronic  fatigue syndrome
Chronic fatigue syndrome
Heba Essawy, MD
 
Amyotrophic lateral sclerosis (als)
Amyotrophic lateral sclerosis (als)Amyotrophic lateral sclerosis (als)
Amyotrophic lateral sclerosis (als)
meekhole
 
Friedreich’s Ataxia
Friedreich’s Ataxia Friedreich’s Ataxia
Friedreich’s Ataxia
D.A.B.M
 
Diabetic neuropathy
Diabetic neuropathyDiabetic neuropathy
Diabetic neuropathy
Dr. Tushar Patil
 
Muscular dystrophies
Muscular dystrophiesMuscular dystrophies
Muscular dystrophies
Manoj Prabhakar
 
Inflammatory Myopathies
Inflammatory MyopathiesInflammatory Myopathies
Inflammatory Myopathies
Ipsita Panda
 
Klippel-Feil Syndrome
Klippel-Feil SyndromeKlippel-Feil Syndrome
Klippel-Feil Syndrome
Dibyendunarayan Bid
 
Approach to myopathy
Approach to myopathyApproach to myopathy
Approach to myopathy
Shivshankar Badole
 
Myopathies
MyopathiesMyopathies
Myopathies
Praveen Nagula
 
Multiple sclerosis
Multiple sclerosisMultiple sclerosis
Multiple sclerosis
Eneutron
 
Inflammatory Myopathies
Inflammatory MyopathiesInflammatory Myopathies
Inflammatory Myopathies
Lohit Chauhan
 
Vasculitis
VasculitisVasculitis
Vasculitis
imrana tanvir
 
MELAS
MELASMELAS
MELAS
Ade Wijaya
 
Adult onset-still-disease-1
Adult onset-still-disease-1Adult onset-still-disease-1
Adult onset-still-disease-1
Born To Win
 
Fibromyalgia
FibromyalgiaFibromyalgia
Fibromyalgia
punita85
 
Presentation 1 1 1
Presentation 1 1 1Presentation 1 1 1
Presentation 1 1 1
DebopriyaChoudhury1
 
Compressive Myelopathy
Compressive MyelopathyCompressive Myelopathy

What's hot (20)

Vasculitis
VasculitisVasculitis
Vasculitis
 
Hereditary spastic paraplegia
Hereditary spastic paraplegiaHereditary spastic paraplegia
Hereditary spastic paraplegia
 
Still's disease
Still's diseaseStill's disease
Still's disease
 
Chronic fatigue syndrome
Chronic  fatigue syndromeChronic  fatigue syndrome
Chronic fatigue syndrome
 
Amyotrophic lateral sclerosis (als)
Amyotrophic lateral sclerosis (als)Amyotrophic lateral sclerosis (als)
Amyotrophic lateral sclerosis (als)
 
Friedreich’s Ataxia
Friedreich’s Ataxia Friedreich’s Ataxia
Friedreich’s Ataxia
 
Diabetic neuropathy
Diabetic neuropathyDiabetic neuropathy
Diabetic neuropathy
 
Muscular dystrophies
Muscular dystrophiesMuscular dystrophies
Muscular dystrophies
 
Inflammatory Myopathies
Inflammatory MyopathiesInflammatory Myopathies
Inflammatory Myopathies
 
Klippel-Feil Syndrome
Klippel-Feil SyndromeKlippel-Feil Syndrome
Klippel-Feil Syndrome
 
Approach to myopathy
Approach to myopathyApproach to myopathy
Approach to myopathy
 
Myopathies
MyopathiesMyopathies
Myopathies
 
Multiple sclerosis
Multiple sclerosisMultiple sclerosis
Multiple sclerosis
 
Inflammatory Myopathies
Inflammatory MyopathiesInflammatory Myopathies
Inflammatory Myopathies
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
MELAS
MELASMELAS
MELAS
 
Adult onset-still-disease-1
Adult onset-still-disease-1Adult onset-still-disease-1
Adult onset-still-disease-1
 
Fibromyalgia
FibromyalgiaFibromyalgia
Fibromyalgia
 
Presentation 1 1 1
Presentation 1 1 1Presentation 1 1 1
Presentation 1 1 1
 
Compressive Myelopathy
Compressive MyelopathyCompressive Myelopathy
Compressive Myelopathy
 

Similar to Adult-Onset Still's Disease

Dr sujeet kumar jha
Dr sujeet kumar jhaDr sujeet kumar jha
Dr sujeet kumar jha
DrSujeet Jha
 
Sagar immunology
Sagar immunologySagar immunology
Sagar immunology
Sagar Kamble
 
Autoimmune diseases_Biochemistry
Autoimmune diseases_BiochemistryAutoimmune diseases_Biochemistry
Autoimmune diseases_Biochemistry
Bangaluru
 
HIV-AIDS.pptx
HIV-AIDS.pptxHIV-AIDS.pptx
HIV-AIDS.pptx
EDUARDOPAOLOPACHECOC
 
Wiskott Aldrich Syndrome Final Powerpoint
Wiskott Aldrich Syndrome Final PowerpointWiskott Aldrich Syndrome Final Powerpoint
Wiskott Aldrich Syndrome Final Powerpoint
Jefferson School of Education
 
Reactive arthritis
Reactive arthritisReactive arthritis
Reactive arthritis
Sachin Giri
 
Thyroid eye disease
Thyroid eye disease Thyroid eye disease
Thyroid eye disease
AVURUCHUKWUNALUJAMES1
 
Immunodeficiency dis order [Repaired] FINAL.pptx
Immunodeficiency dis order [Repaired] FINAL.pptxImmunodeficiency dis order [Repaired] FINAL.pptx
Immunodeficiency dis order [Repaired] FINAL.pptx
NimonaAAyele
 
CP-Recurrent infections 2022 students without MCQ.ppt
CP-Recurrent infections 2022 students without MCQ.pptCP-Recurrent infections 2022 students without MCQ.ppt
CP-Recurrent infections 2022 students without MCQ.ppt
MUHAMMADCHAUDHRY39
 
Non-IPF ILD & MMF.pptx
Non-IPF ILD & MMF.pptxNon-IPF ILD & MMF.pptx
Non-IPF ILD & MMF.pptx
Subhajit Ghosh
 
All blood diseases
All blood diseasesAll blood diseases
All blood diseases
Pranjali Mahajan
 
assisgnment.pptx
assisgnment.pptxassisgnment.pptx
assisgnment.pptx
KaliDereje
 
Autoimmunity
AutoimmunityAutoimmunity
Autoimmunity
Omair Riaz
 
Systemic lupus erythematosus
Systemic lupus erythematosusSystemic lupus erythematosus
Systemic lupus erythematosus
Koustav Jana
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
Fatima Elsamani
 
Kawasaki Syndrome
Kawasaki SyndromeKawasaki Syndrome
Kawasaki Syndrome
Enrico Bonnì
 
GROUP THREE.pptx
GROUP THREE.pptxGROUP THREE.pptx
GROUP THREE.pptx
FrancisEtseyDushie
 
Septic shock sirs and mof
Septic shock  sirs and mofSeptic shock  sirs and mof
Septic shock sirs and mof
Osama Omar
 
HIV and Opportunistic infections-WPS Office.pptx
HIV and Opportunistic infections-WPS Office.pptxHIV and Opportunistic infections-WPS Office.pptx
HIV and Opportunistic infections-WPS Office.pptx
Sudipta Roy
 
Autoimmune Disease By Bishajit debnath
Autoimmune Disease By Bishajit debnath Autoimmune Disease By Bishajit debnath
Autoimmune Disease By Bishajit debnath
Primeasia University
 

Similar to Adult-Onset Still's Disease (20)

Dr sujeet kumar jha
Dr sujeet kumar jhaDr sujeet kumar jha
Dr sujeet kumar jha
 
Sagar immunology
Sagar immunologySagar immunology
Sagar immunology
 
Autoimmune diseases_Biochemistry
Autoimmune diseases_BiochemistryAutoimmune diseases_Biochemistry
Autoimmune diseases_Biochemistry
 
HIV-AIDS.pptx
HIV-AIDS.pptxHIV-AIDS.pptx
HIV-AIDS.pptx
 
Wiskott Aldrich Syndrome Final Powerpoint
Wiskott Aldrich Syndrome Final PowerpointWiskott Aldrich Syndrome Final Powerpoint
Wiskott Aldrich Syndrome Final Powerpoint
 
Reactive arthritis
Reactive arthritisReactive arthritis
Reactive arthritis
 
Thyroid eye disease
Thyroid eye disease Thyroid eye disease
Thyroid eye disease
 
Immunodeficiency dis order [Repaired] FINAL.pptx
Immunodeficiency dis order [Repaired] FINAL.pptxImmunodeficiency dis order [Repaired] FINAL.pptx
Immunodeficiency dis order [Repaired] FINAL.pptx
 
CP-Recurrent infections 2022 students without MCQ.ppt
CP-Recurrent infections 2022 students without MCQ.pptCP-Recurrent infections 2022 students without MCQ.ppt
CP-Recurrent infections 2022 students without MCQ.ppt
 
Non-IPF ILD & MMF.pptx
Non-IPF ILD & MMF.pptxNon-IPF ILD & MMF.pptx
Non-IPF ILD & MMF.pptx
 
All blood diseases
All blood diseasesAll blood diseases
All blood diseases
 
assisgnment.pptx
assisgnment.pptxassisgnment.pptx
assisgnment.pptx
 
Autoimmunity
AutoimmunityAutoimmunity
Autoimmunity
 
Systemic lupus erythematosus
Systemic lupus erythematosusSystemic lupus erythematosus
Systemic lupus erythematosus
 
Rheumatoid arthritis
Rheumatoid arthritisRheumatoid arthritis
Rheumatoid arthritis
 
Kawasaki Syndrome
Kawasaki SyndromeKawasaki Syndrome
Kawasaki Syndrome
 
GROUP THREE.pptx
GROUP THREE.pptxGROUP THREE.pptx
GROUP THREE.pptx
 
Septic shock sirs and mof
Septic shock  sirs and mofSeptic shock  sirs and mof
Septic shock sirs and mof
 
HIV and Opportunistic infections-WPS Office.pptx
HIV and Opportunistic infections-WPS Office.pptxHIV and Opportunistic infections-WPS Office.pptx
HIV and Opportunistic infections-WPS Office.pptx
 
Autoimmune Disease By Bishajit debnath
Autoimmune Disease By Bishajit debnath Autoimmune Disease By Bishajit debnath
Autoimmune Disease By Bishajit debnath
 

More from Systemic JIA Foundation

Social hour - Rare Disease Day 2023
Social hour - Rare Disease Day 2023 Social hour - Rare Disease Day 2023
Social hour - Rare Disease Day 2023
Systemic JIA Foundation
 
New Treatments for SJIA
New Treatments for SJIANew Treatments for SJIA
New Treatments for SJIA
Systemic JIA Foundation
 
Leading Quality Improvements in Pediatric Rheumatology Care - Dr. Esi Morgan
Leading Quality Improvements in Pediatric Rheumatology Care - Dr. Esi MorganLeading Quality Improvements in Pediatric Rheumatology Care - Dr. Esi Morgan
Leading Quality Improvements in Pediatric Rheumatology Care - Dr. Esi Morgan
Systemic JIA Foundation
 
What is SJIA - How is it different than other diseases - Dr. Hermine Brunner
What is SJIA - How is it different than other diseases - Dr. Hermine BrunnerWhat is SJIA - How is it different than other diseases - Dr. Hermine Brunner
What is SJIA - How is it different than other diseases - Dr. Hermine Brunner
Systemic JIA Foundation
 
Current Clinical Trials in SJIA & MAS - Dr. Daniel Lovell
Current Clinical Trials in SJIA & MAS - Dr. Daniel LovellCurrent Clinical Trials in SJIA & MAS - Dr. Daniel Lovell
Current Clinical Trials in SJIA & MAS - Dr. Daniel Lovell
Systemic JIA Foundation
 
Research Updates in SJIA & MAS - Grant Schulert
Research Updates in SJIA & MAS - Grant SchulertResearch Updates in SJIA & MAS - Grant Schulert
Research Updates in SJIA & MAS - Grant Schulert
Systemic JIA Foundation
 
Macrophage Activation Syndrome in SJIA - Alexei Grom
Macrophage Activation Syndrome in SJIA - Alexei GromMacrophage Activation Syndrome in SJIA - Alexei Grom
Macrophage Activation Syndrome in SJIA - Alexei Grom
Systemic JIA Foundation
 
Treating new and refractory SJIA patients - Jennifer Huggins
Treating new and refractory SJIA patients - Jennifer HugginsTreating new and refractory SJIA patients - Jennifer Huggins
Treating new and refractory SJIA patients - Jennifer Huggins
Systemic JIA Foundation
 
COPA mutations impair Golgi-ER transport causing hereditary autoimmune-mediat...
COPA mutations impair Golgi-ER transport causing hereditary autoimmune-mediat...COPA mutations impair Golgi-ER transport causing hereditary autoimmune-mediat...
COPA mutations impair Golgi-ER transport causing hereditary autoimmune-mediat...
Systemic JIA Foundation
 
Childrens Interstitial Lung Disease Clinical Overview
Childrens Interstitial Lung Disease Clinical OverviewChildrens Interstitial Lung Disease Clinical Overview
Childrens Interstitial Lung Disease Clinical Overview
Systemic JIA Foundation
 
Molecular Mechanisms in ILD in Adult Connective Tissue Disease
Molecular Mechanisms in ILD in Adult Connective Tissue DiseaseMolecular Mechanisms in ILD in Adult Connective Tissue Disease
Molecular Mechanisms in ILD in Adult Connective Tissue Disease
Systemic JIA Foundation
 
Epigenetics and cell fate in JIA and pulmonary fibrosis by Jim Hagood
Epigenetics and cell fate in JIA and pulmonary fibrosis by Jim HagoodEpigenetics and cell fate in JIA and pulmonary fibrosis by Jim Hagood
Epigenetics and cell fate in JIA and pulmonary fibrosis by Jim Hagood
Systemic JIA Foundation
 
Systemic JIA the Clinical Picture
Systemic JIA the Clinical PictureSystemic JIA the Clinical Picture
Systemic JIA the Clinical Picture
Systemic JIA Foundation
 
Rare Pulmonary Diseases in Systemic JIA
Rare Pulmonary Diseases in Systemic JIARare Pulmonary Diseases in Systemic JIA
Rare Pulmonary Diseases in Systemic JIA
Systemic JIA Foundation
 
Immune Mechanisms of Inflamation in SJIA
Immune Mechanisms of Inflamation in SJIAImmune Mechanisms of Inflamation in SJIA
Immune Mechanisms of Inflamation in SJIA
Systemic JIA Foundation
 

More from Systemic JIA Foundation (15)

Social hour - Rare Disease Day 2023
Social hour - Rare Disease Day 2023 Social hour - Rare Disease Day 2023
Social hour - Rare Disease Day 2023
 
New Treatments for SJIA
New Treatments for SJIANew Treatments for SJIA
New Treatments for SJIA
 
Leading Quality Improvements in Pediatric Rheumatology Care - Dr. Esi Morgan
Leading Quality Improvements in Pediatric Rheumatology Care - Dr. Esi MorganLeading Quality Improvements in Pediatric Rheumatology Care - Dr. Esi Morgan
Leading Quality Improvements in Pediatric Rheumatology Care - Dr. Esi Morgan
 
What is SJIA - How is it different than other diseases - Dr. Hermine Brunner
What is SJIA - How is it different than other diseases - Dr. Hermine BrunnerWhat is SJIA - How is it different than other diseases - Dr. Hermine Brunner
What is SJIA - How is it different than other diseases - Dr. Hermine Brunner
 
Current Clinical Trials in SJIA & MAS - Dr. Daniel Lovell
Current Clinical Trials in SJIA & MAS - Dr. Daniel LovellCurrent Clinical Trials in SJIA & MAS - Dr. Daniel Lovell
Current Clinical Trials in SJIA & MAS - Dr. Daniel Lovell
 
Research Updates in SJIA & MAS - Grant Schulert
Research Updates in SJIA & MAS - Grant SchulertResearch Updates in SJIA & MAS - Grant Schulert
Research Updates in SJIA & MAS - Grant Schulert
 
Macrophage Activation Syndrome in SJIA - Alexei Grom
Macrophage Activation Syndrome in SJIA - Alexei GromMacrophage Activation Syndrome in SJIA - Alexei Grom
Macrophage Activation Syndrome in SJIA - Alexei Grom
 
Treating new and refractory SJIA patients - Jennifer Huggins
Treating new and refractory SJIA patients - Jennifer HugginsTreating new and refractory SJIA patients - Jennifer Huggins
Treating new and refractory SJIA patients - Jennifer Huggins
 
COPA mutations impair Golgi-ER transport causing hereditary autoimmune-mediat...
COPA mutations impair Golgi-ER transport causing hereditary autoimmune-mediat...COPA mutations impair Golgi-ER transport causing hereditary autoimmune-mediat...
COPA mutations impair Golgi-ER transport causing hereditary autoimmune-mediat...
 
Childrens Interstitial Lung Disease Clinical Overview
Childrens Interstitial Lung Disease Clinical OverviewChildrens Interstitial Lung Disease Clinical Overview
Childrens Interstitial Lung Disease Clinical Overview
 
Molecular Mechanisms in ILD in Adult Connective Tissue Disease
Molecular Mechanisms in ILD in Adult Connective Tissue DiseaseMolecular Mechanisms in ILD in Adult Connective Tissue Disease
Molecular Mechanisms in ILD in Adult Connective Tissue Disease
 
Epigenetics and cell fate in JIA and pulmonary fibrosis by Jim Hagood
Epigenetics and cell fate in JIA and pulmonary fibrosis by Jim HagoodEpigenetics and cell fate in JIA and pulmonary fibrosis by Jim Hagood
Epigenetics and cell fate in JIA and pulmonary fibrosis by Jim Hagood
 
Systemic JIA the Clinical Picture
Systemic JIA the Clinical PictureSystemic JIA the Clinical Picture
Systemic JIA the Clinical Picture
 
Rare Pulmonary Diseases in Systemic JIA
Rare Pulmonary Diseases in Systemic JIARare Pulmonary Diseases in Systemic JIA
Rare Pulmonary Diseases in Systemic JIA
 
Immune Mechanisms of Inflamation in SJIA
Immune Mechanisms of Inflamation in SJIAImmune Mechanisms of Inflamation in SJIA
Immune Mechanisms of Inflamation in SJIA
 

Recently uploaded

Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
MuskanShingari
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
DrGirishJHoogar
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 
Foundation of Yoga, YCB Level-3, Unit-1
Foundation of Yoga, YCB Level-3, Unit-1 Foundation of Yoga, YCB Level-3, Unit-1
Foundation of Yoga, YCB Level-3, Unit-1
Jyoti Bhaghasra
 
SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.
KULDEEP VYAS
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Kunj Vihari
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
5 Effective Homeopathic Medicines for Irregular Periods
5 Effective Homeopathic Medicines for Irregular Periods5 Effective Homeopathic Medicines for Irregular Periods
5 Effective Homeopathic Medicines for Irregular Periods
Dr. Deepika's Homeopathy - Gaur City
 
Local anesthetics 2024/ Medicinal Chemistry pdf
Local anesthetics 2024/ Medicinal Chemistry pdfLocal anesthetics 2024/ Medicinal Chemistry pdf
Local anesthetics 2024/ Medicinal Chemistry pdf
NarminHamaaminHussen
 
13. PROM premature rupture of membranes
13.  PROM premature rupture of membranes13.  PROM premature rupture of membranes
13. PROM premature rupture of membranes
TigistuMelak
 
Patellar Instability: Diagnosis Management
Patellar Instability: Diagnosis  ManagementPatellar Instability: Diagnosis  Management
Patellar Instability: Diagnosis Management
Dr Nitin Tyagi
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
PGx Analysis in VarSeq: A User’s Perspective
PGx Analysis in VarSeq: A User’s PerspectivePGx Analysis in VarSeq: A User’s Perspective
PGx Analysis in VarSeq: A User’s Perspective
Golden Helix
 
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
Gokuldas Hospital
 
biomechanics of running. Dr.dhwani.pptx
biomechanics of running.   Dr.dhwani.pptxbiomechanics of running.   Dr.dhwani.pptx
biomechanics of running. Dr.dhwani.pptx
Dr. Dhwani kawedia
 
Giloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and SynonymsGiloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and Synonyms
Planet Ayurveda
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Jim Jacob Roy
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 

Recently uploaded (20)

Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 
Foundation of Yoga, YCB Level-3, Unit-1
Foundation of Yoga, YCB Level-3, Unit-1 Foundation of Yoga, YCB Level-3, Unit-1
Foundation of Yoga, YCB Level-3, Unit-1
 
SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.
 
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
5 Effective Homeopathic Medicines for Irregular Periods
5 Effective Homeopathic Medicines for Irregular Periods5 Effective Homeopathic Medicines for Irregular Periods
5 Effective Homeopathic Medicines for Irregular Periods
 
Local anesthetics 2024/ Medicinal Chemistry pdf
Local anesthetics 2024/ Medicinal Chemistry pdfLocal anesthetics 2024/ Medicinal Chemistry pdf
Local anesthetics 2024/ Medicinal Chemistry pdf
 
13. PROM premature rupture of membranes
13.  PROM premature rupture of membranes13.  PROM premature rupture of membranes
13. PROM premature rupture of membranes
 
Patellar Instability: Diagnosis Management
Patellar Instability: Diagnosis  ManagementPatellar Instability: Diagnosis  Management
Patellar Instability: Diagnosis Management
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
PGx Analysis in VarSeq: A User’s Perspective
PGx Analysis in VarSeq: A User’s PerspectivePGx Analysis in VarSeq: A User’s Perspective
PGx Analysis in VarSeq: A User’s Perspective
 
How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.How to Control Your Asthma Tips by gokuldas hospital.
How to Control Your Asthma Tips by gokuldas hospital.
 
biomechanics of running. Dr.dhwani.pptx
biomechanics of running.   Dr.dhwani.pptxbiomechanics of running.   Dr.dhwani.pptx
biomechanics of running. Dr.dhwani.pptx
 
Giloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and SynonymsGiloy in Ayurveda - Classical Categorization and Synonyms
Giloy in Ayurveda - Classical Categorization and Synonyms
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdfMedical Quiz ( Online Quiz for API Meet 2024 ).pdf
Medical Quiz ( Online Quiz for API Meet 2024 ).pdf
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 

Adult-Onset Still's Disease

  • 1. Adult-Onset Still’s Disease Dr. Bella Mehta Hospital for Special Surgery Weill Cornell Medical College @bella_mehta
  • 2. Overview • Adult Onset Still’s Disease (AOSD) is a rare autoinflammatory syndrome • ~1.6 cases per 1,000,000 individuals, affecting men and women equally • Most commonly affects patients between 15-25 and 36-46 years old • Many patients live full, normal lives with proper treatment Mandl L, et al. Treatment of adult-onset Still's disease. Up to Date. 2021
  • 3. Why does AOSD occur? Genetic factors Viral infection Immune dysregulation Epstein-Barr Rubella IL-1 IL-6 IL-17 IL-18 TNF - alpha Several factors associated with AOSD
  • 4. AOSD Disease Patterns Monocyclic/Self-Limited One flare/active phase Lasts weeks to months Usually resolves in <1 year Systemic features (fever, rash, serositis) Intermittent Pattern ≥1 disease flare Complete remission between episodes Articular symptoms Chronic Pattern Constant active disease No remission Articular symptoms Destructive arthritis
  • 5. Still’s Disease Triad AOSD Daily fevers Early afternoon/evening Evanescent rash Salmon-pink, on trunk or extremities, occurs with fever Arthritis Small joints more often than large joints
  • 6. AOSD Rash Evanescent (tends to disappear quickly) rash that is most common during a fever episode Left image: Courant V, et al. Rare presentation of adult Still's disease in an African American male. Journal of Hospital Medicine, 2022 Center image: Gopalarathinim R, et al. Adult Onset Still's Disease: A Review on Diagnostic Workup and Treatment Options. Case Reports in Rheum, 2016;6:1-6. Right image: Patra S, et al. Adult-onset Still's disease presenting as blotchy and flagellate pigmentation. Indian J Dermatol Venereol Leprol, 2019;85:626-628.
  • 7. Clinical Features Common Symptoms Uncommon Symptoms Fever Hepatomegaly (enlarged liver) Rash Pleurisy (inflammation of lung lining) Arthritis Pericarditis (inflammation of the heart lining) Arthralgia (body aches) Abdominal pain Myalgias (muscle pain) Macrophage activation syndrome (MAS) Sore Throat Lymphadenopathy (swelling of lymph nodes) Splenomegaly (enlarged spleen)
  • 8. Comorbidities • Our Nationwide study examined variations in morbidity and mortality 5 year data • 65.6% of patients were female • Mean age of pts who died in hospital 62.4 • Higher odds of in-hospital death in Asian patients • Other possible complications that may occur in AOSD include: • Overwhelming infection • Liver failure • Amyloidosis (protein buildup) 5,820 Hospitalized AOSD Patients • Heart failure *Racial/Ethnic variations in morbidity and mortality in Adult Onset Still’s Disease: An analysis of national dataset, Seminars in arthritis and Rheumatism 2019
  • 9. Goals of Therapy Vary with severity of disease 1. Control inflammation 2. Prevent joint damage 3. Minimize risk of adverse events 4. Lessen burden of disease NSAIDS Corticosteroids DMARDs
  • 10. Diagnosis and Next Steps Confirmation of diagnosis is critical • Several other systemic conditions have similar symptoms to AOSD Screen for underlying conditions and immunize if necessary • Ex. hepatitus virus screening, testing for latent tuberculosis Determine whether macrophage activation syndrome (MAS) is present • Also known as a cytokine storm Assess disease activity and severity • Informs treatment (ex. medications) Mandl L, et al. Treatment of adult-onset Still's disease. Up to Date. 2021
  • 11. Dr. Bella Mehta Hospital for Special Surgery Weill Cornell Medical College Thank You! Questions? @bella_mehta
  • 12. Diagnosis Efthimiou, P. New York Rheumatology Care, New York, NY. Ross University School of Medicine 1. Yamaguchi M, et al. J Rheumatol. 1992,19:424-430. 2. Fautrel B, et al. Medicine (Baltimore). 2002;81:194-200.
  • 13. Medications • Traditional medications • Nonsteroidal anti-inflammatory drugs (NSAIDs) • Glucocorticoids • Biologics • Canakinumab • Anakinra • Infliximab • Rilonacept • Etanercept • Adalimumab • Tocilizumab • Rituximab • Disease-modifying antirheumatic drugs (DMARDs) • Hydroxychloroquine • Methotrexate • Leflunomide • Cyclosporine • Azathioprine • Tacrolimus
  • 14. Comorbidities • AOSD is infrequently associated with morbidity and life-threatening comorbidities • Complications include: • Overwhelming infection • Liver failure • Amyloidosis (protein buildup in organs) • Adult respiratory distress syndrome • Heart failure • Macrophage activation syndrome (MAS) • Pulmonary hypertension Early recognition and treatment can significantly decrease the risk of complications Efthimiou P, Mehta B. Life-threatening complications of adult-onset Still’s disease. Clin Rheumatol. 2014;33:305-314.

Editor's Notes

  1. Comorbidities are common in AOSD Serious infection Malignancy Infection Cardiovascular events
  2. Genetic factors: Increased HLA-DP and HLA-DR Decreased HLA-DQ
  3. Need to know the N US-wide dataset Emphasize that work has been done 5 lines Other things include (what is listed on slide 8) Try to fit on 1 slide, 2 if necessary